IDEXX stock jumps 12% as Q4 report, outlook top Street estimates
IDEXX (IDXX) stock jumped 12% in early trading Monday after the pet healthcare company issued a Q4 earnings report and 2025 forecast that topped Street expectations. Read more here.
IDEXX Laboratories Stock Rises 11% Following Strong Q4 Earnings And Revenue Growth
IDEXX Laboratories, Inc. (IDXX) is up by 11.55 percent during Friday morning trading, following the release of its fourth-quarter
Idexx Labs 4Q Revenue Tops Estimates; 2025 Outlook Issued
Idexx forecast revenue between $4.06 billion and $4.17 billion in 2025, in line with analysts' estimates of $4.14 billion. The company also guided for earnings per share in the range of $11.74 and $12.24 for the year, while analysts expected $11.94 a share.
IDEXX Laboratories, Inc. (IDXX) Q4 2024 Earnings Call Transcript
IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & Companion Animal Group Finance Jay Mazelsky - President & Chief Executive Officer
Idexx: Q4 Earnings Snapshot
For the year, the company reported profit of $887.9 million, or $10.67 per share. Revenue was reported as $3.9 billion. Idexx expects full-year earnings to be $11.74 to $12.24 per share, with revenue in the range of $4.06 billion to $4.17 billion.
IDEXX Laboratories Inc Profit Climbs In Q4, Beats Estimates
IDEXX Laboratories Inc (IDXX) revealed earnings for its fourth quarter that increased from last year and beat the Street estimates.
Idexx: Q4 EPS, Revenue Beat Forecast
Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.
These Stocks Are Moving the Most Today: Tesla, GM, Nvidia, Constellation Brands, Idexx, Palantir, and More
Stocks were falling Monday but came off sharp lows as President Donald Trump’s delay to tariffs on Mexico for a month had ...
Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits
IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...
Idexx Laboratories reports Q4 EPS $2.62, consensus $2.40
Reports Q4 revenue $954M, consensus $936.68M. “IDEXX had a solid finish to 2024, supported by continued high levels of execution by IDEXX teams ...
American Association of Individual Investors1d
Why IDEXX Laboratories, Inc.’s (IDXX) Stock Is Up 11.13%
IDEXX Laboratories, Inc.’s IDXX share price has surged by 11.13%, which has investors questioning if this is right time to ...
dvm3607d
Affordable early detection test for canine lymphoma to hit the market
IDEXX Laboratories shared earlier this month the launch of IDEXX Cancer Dx, a diagnostic panel with early detection of ...
Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today’s Top S&P 500 Performers.
Idexx Laboratories stock was rising sharply Monday, even as the S&P 500 and major indexes remained in the red. The Dow Jones ...
Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?
IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the ...
IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices
Key Takeaways IDEXX Laboratories exceeded earnings and revenue estimates on sales of its animal testing products and price ...